June 25, 2021 Acad, Gov/Utilities Clinical Research/Diagn. Microscopy PR/Corporate

Roche’s Actemra/RoActemra receives U.S. FDA Emergency Use Authorization for the treatment of COVID-19 in hospitalised adults and children

The authorisation enables emergency use of Actemra/RoActemra for the treatment of COVID-19 in hospitalised adult and paediatric patients Basel, 25 June 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for intravenous Actemra/RoActemra® (tocilizumab) for the treatment of COVID-19... Read more

June 23, 2021 Clinical Research/Diagn. Liq. Handling & Robotics M&A, Partnerships

Tecan expands its commercial reach, its capabilities and its US and Asia presence with the acquisition of Paramit Corporation

Tecan to acquire Paramit Corporation, a leading OEM developer and manufacturer of medical devices and life sciences instruments, for a total consideration of USD 1.0 billion (CHF 920 million)  In full year 2021, Paramit is expected to generate around USD 280m in sales (CHF 257m) and around USD 50m EBITDA (CHF 46m), before acquisition-related costs  Transaction expected to be immediately and significantly accretive to earnings per share (EPS) upon closing  Adds complementary expertise, broadens design, development and manufacturing capabilities Expansion into the attractive and fast-growing medical... Read more

June 16, 2021 Atomic Spectroscopy Clinical Research/Diagn. Lab Top-10

Thermo Fisher Scientific Announces Oncomine Clinical Research Grant Program Call for Submissions to Support Research in Immuno-oncology

Thermo Fisher Scientific Announces Oncomine Clinical Research Grant Program Call for Submissions to Support Research in Immuno-oncology CARLSBAD, Calif., June 16, 2021 /PRNewswire/ — Thermo Fisher Scientific today announced that submissions are now open for the Oncomine Clinical Research Grant program to support clinical research projects in oncology. This grant aims to provide funding for high-quality molecular... Read more

June 14, 2021 Clinical Research/Diagn. Lab Top-10 Product Launch

Thermo Fisher Scientific Introduces New Quick to Clinic Solution to Help Biologic Drug Developers Accelerate Preclinical Development at BIO Digital 2021

Thermo Fisher Scientific Introduces New Quick to Clinic Solution to Help Biologic Drug Developers Accelerate Preclinical Development at BIO Digital 2021 Enhanced solution delivers balance of speed and quality to accelerate and expedite DNA to Investigational New Drug in as little as 13 months WALTHAM, Mass., June 14, 2021 /PRNewswire/ — BIO DIGITAL 2021 – New... Read more

June 8, 2021 Cell Analysis Tools Clinical Research/Diagn. M&A, Partnerships

Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium

JUNE 08, 2021 MINNEAPOLIS, June 8, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced it is joining the Cell and Gene Therapy Catapult process analytical technology (PAT) consortium, which includes over 20 pharmaceutical companies, technology providers, therapy developers, and charities.  The consortium will assess the application and combination of multiple technologies for process analytics within... Read more

May 17, 2021 Chromatography Clinical Research/Diagn. Lab Top-10 Life Science Tools M&A, Partnerships Microscopy

PerkinElmer to Acquire In-Vitro Diagnostics Company Immunodiagnostic Systems Holdings PLC

Endocrinology testing specialist expands PerkinElmer’s immunodiagnostics segment WALTHAM, Mass.–(BUSINESS WIRE)–May 17, 2021– PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) and Immunodiagnostic Systems Holdings PLC (LSE: IHS) (“IDS”) are pleased to announce that they have reached an agreement on the terms of a recommended all cash offer whereby PerkinElmer will acquire IDS for approximately $155 million (£110 Million).... Read more

May 11, 2021 Clinical Research/Diagn. PAI Top-10 Product Launch

Roche to present data from one of the most comprehensive oncology portfolios at the 2021 ASCO Annual Meeting showcasing advancements for people living with cancer

Data from the first positive phase III study of a cancer immunotherapy in early, resected lung cancer Studies in personalised healthcare exploring tumour agnostic treatments that demonstrate the impact of coupling biomarker testing with targeted therapies to develop individualised treatment plans New data, and drug combination strategies for the treatment of lymphoma from the largest... Read more

May 4, 2021 Bio/Pharma/CRO Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Bio-Techne and 908 Devices Announce Joint Collaboration

MAY 04, 2021 MINNEAPOLIS and BOSTON, May 4, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) and 908 Devices (NASDAQ: MASS) today announced a joint collaboration to develop an extended workflow solution for protein characterization. Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, and owner of the leading ProteinSimple... Read more

April 23, 2021 Acad, Gov/Utilities Bio/Pharma/CRO Clinical Research/Diagn. PAI Top-10 PR/Corporate

Roche receives FDA approval for first companion diagnostic to identify endometrial cancer patients eligible for immunotherapy

About 90,000 women globally die from endometrial cancer each year1 VENTANA MMR RxDx Panel is the first immunohistochemistry predictive test in endometrial cancer for treatment with the anti-PD1 immunotherapy JEMPERLI (dostarlimab-gxly) Roche/GSK collaboration represents an important step towards a personalised healthcare strategy that can help identify patients who are most likely to benefit from a... Read more